Norris Medicines Ltd — Insider Trade, 27-06-2025: Insider Trading / SAST

Norris Medicines Limited has announced a trading window closure starting 1st July 2025, lasting until 48 hours after the announcement of the financial results for the quarter ended 30th June 2025. During this period, designated persons including promoters, directors, auditors, and key management personnel along with their immediate relatives are restricted from trading in the company’s securities. This measure ensures compliance with the company’s insider trading code and maintains market integrity ahead of the quarterly financial disclosure.